Drugs Made In America Acquisition (DMIIR) Accumulated Expenses (2025 - 2026)
Drugs Made In America Acquisition (DMIIR) posted quarterly Accumulated Expenses of $88343.0 for Q4 2025, up 1411.95% quarter-over-quarter from $5843.0 in Q3 2025.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIR) Accumulated Expenses (2025 - 2026) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has reported Accumulated Expenses for 1 consecutive years, with $88343.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Accumulated Expenses changed N/A year-over-year to $88343.0; the TTM figure through Dec 2025 stood at $88343.0 (changed N/A YoY), while the FY2025 annual figure was $88343.0, changed N/A from the prior year.
- Accumulated Expenses rose to $88343.0 in Q4 2025 per DMIIR's latest filing, from $5843.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $88343.0 in Q4 2025 and bottomed at $5843.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - |
| 3 | K&F Growth Acquisition | 836.15 Mn | 836.15 Mn | - |
| 4 | Armada Acquisition | 666.54 Mn | 666.49 Mn | - |
| 5 | Pioneer Acquisition I | 652.74 Mn | 652.27 Mn | - |
| 6 | Oxley Bridge Acquisition | 652.11 Mn | 652.11 Mn | - |
| 7 | Titan Acquisition | 651.43 Mn | 941.85 Mn | - |
| 8 | GSR IV Acquisition | 622.22 Mn | 622.22 Mn | - |
| 9 | Launch One Acquisition | 618.70 Mn | 618.70 Mn | - |
| 10 | Drugs Made In America Acquisition | 5.10 Mn | 5.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69,159.00 |
| Dec 31, 2025 | 88,343.00 |
| Sep 30, 2025 | 5,843.00 |